We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AdvaMed will make global harmonization a top priority over the next two years, incoming chairman and Covidien CEO Jose “Joe” Almeida said on a Wednesday press call. Read More
“Accurate detection … is critically important in efforts to successfully detect and potentially reduce the incidence of cervical cancer,” Cepheid CEO John Bishop says. Read More
Johnson and Johnson said Monday that it accepted an offer from The Carlyle Group, extended in January, to acquire Raritan, N.J.-based Ortho-Clinical Diagnostics. Read More
The FDA has approved St. Jude Medical’s Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P), Assurity pacemaker and Endurity pacemaker families of devices. Read More